Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/137544
Title: Why breast cancer signatures are no better than random signatures explained
Authors: Goh, Wilson Wen Bin
Wong, Limsoon
Keywords: Science::Biological sciences
Issue Date: 2018
Source: Goh, W. W. B., & Wong, L. (2018). Why breast cancer signatures are no better than random signatures explained. Drug Discovery Today, 23(11), 1818-1823. doi:10.1016/j.drudis.2018.05.036
Journal: Drug Discovery Today 
Abstract: Random signature superiority (RSS) occurs when random gene signatures outperform published and/or known signatures. Unlike reproducibility and generalizability issues, RSS is relatively underexplored. Yet, understanding it is imperative for better analytical outcome. In breast cancer, RSS correlates strongly with enrichment for proliferation genes and signature size. Removal of proliferation genes from random signatures reduces the predictive power of random signatures. Almost all genes are correlated to a certain extent with the proliferation signature, making complete elimination of its confounding effects impossible. RSS goes beyond breast cancer, because it also exists in other diseases; it is especially strong in other cancers in a platform-independent manner, and less severe, but present nonetheless, in nonproliferative diseases.
URI: https://hdl.handle.net/10356/137544
ISSN: 1359-6446
DOI: 10.1016/j.drudis.2018.05.036
Rights: © 2018 Elsevier Ltd. All rights reserved. This paper was published in Drug Discovery Today and is made available with permission of Elsevier Ltd.
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:SBS Journal Articles

Files in This Item:
File Description SizeFormat 
Breast Cancer Signatures Are No Better Than Random Signatures Explained.pdf664.22 kBAdobe PDFView/Open

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.